VSEE HEALTH Business Summary

VSee Health, Inc. (VSEE) operates a dual-segment business model comprising Healthcare Technology and Telehealth Services, generating revenue through SaaS subscriptions, professional engineering fees, and per-visit patient fees. The Healthcare Technology segment provides a no-code/low-code AI infrastructure and API-driven platform for secure video collaboration and EMR integration, while the Telehealth Services segment—bolstered by the acquisition of iDoc—delivers high-acuity virtual care, including teleradiology and remote ICU monitoring. Positioned as a "pick and shovel" provider for the AI healthcare sector, VSee differentiates itself from competitors like Amwell, RingCentral, and CareCloud by maintaining FedRAMP High authorization and focusing on complex, hospital-grade clinical workflows rather than general consumer-facing telehealth. The company is led by Co-CEOs Dr. Milton Chen, who also serves as Chairman, and Dr. Imoigele Aisiku, a board-certified neurocritical care specialist and founder of iDoc. Dr. Chen, who developed VSee’s core technology during his PhD research at Stanford University, is supported by Co-Founder and Chief Product Officer Dr. Erika Chuang and CTO Dr. Torrey Lyons, both of whom hold advanced degrees from Stanford and Caltech, respectively. The executive team includes CFO Jerry Leonard and COO George McNellage, overseeing a strategy backed by notable investors such as In-Q-Tel and Salesforce Ventures. The board of directors features independent members with deep healthcare and legal expertise, including Kevin Lowdermilk and Cydonii Fairfax, guiding the company’s expansion into federal and large-scale institutional markets.